-
公开(公告)号:NO20013731A
公开(公告)日:2001-09-18
申请号:NO20013731
申请日:2001-07-30
Applicant: ABBOTT LAB
Inventor: BUNNELLE WILLIAM H , CRISTINA DANIELA BARLOCCO , DAANEN JEROME F , DART MICHAEL J , MEYER MICHAEL D , RYTHER KEITH B , SCHRIMPF MICHAEL R , SIPPY KEVIN B , TOUPENCE RICHARD B
IPC: A61K31/00 , A61K31/407 , A61K31/4355 , A61K31/4365 , A61K31/439 , A61K31/4439 , A61K31/444 , A61K31/4709 , A61K31/497 , A61K31/501 , A61K31/502 , A61P9/10 , A61P15/10 , A61P25/00 , A61P25/02 , A61P25/06 , A61P25/08 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , C07D401/08 , C07D471/08 , C07D487/08 , C07D491/048 , C07D495/04 , C07D519/00 , A61K31/395
CPC classification number: C07D471/08 , C07D401/08 , C07D487/08
-
32.
公开(公告)号:NZ335810A
公开(公告)日:2001-03-30
申请号:NZ33581097
申请日:1997-12-10
Applicant: ABBOTT LAB
Inventor: HOLLADAY MARK W , ARNERIC STEPHEN P , BAI HAO , DART MICHAEL J , LIN NAN-HORNG , LYNCH JOHN K , OR YAT SUN , RYTHER KEITH B , SULLIVAN JAMES P , WASICAK JAMES T , ERHLICH PAUL P
IPC: A61P25/04 , A61K31/4427 , A61K31/443 , A61K31/4439 , A61K31/485 , A61P25/28 , A61P29/00 , C07D205/04 , C07D401/12 , C07D401/14 , C07D405/14
Abstract: An 3-(2-azetidinyl-methoxy)-pyridine derivative or a pharmaceutically acceptable salt thereof has the compound of formula I wherein: Z, Y, X and the 2-azetidine stereochemistry are, respectively, selected from: a) H, H, Me (R); b) H, H, CN (S); c) H, H, Cl (S); d) H, H, Cl (R); e) H, H, Br (R); f) H, H, F (S); g) H, H, F (R); h) H, H, CHF2 (S); i) H, H, OMe (R); j) H, Me, Cl (S); k) H, Me, Cl (R); l) H, Et, F (S); m) H, ethenyl, Cl (S); n) H, ethenyl, Cl (R); o) H, ethenyl, F (S); p) H, ethenyl, F (R); q) H, ethynyl, Cl (S); r) H, ethynyl, Cl (R); s) H, Cl, Cl (S); t) H, Cl, Cl (R); u) H, Cl, F (S); v) H, Br, Me (S); w) H, Br, Me (R); x) H, Br, Cl (S); y) H, Br, Cl (R); z) H, Br, F (S); aa) H, Br, F (R); bb) H, n-Pr, H (S); cc) H, ethenyl, H (S); dd) H, ethenyl, H (R); ee) H, Cl, H (R); ff) H, F, H (S); gg) H, NO2, H (S); hh) H, OEt, H (S); ii) Cl, H, H (S); jj) Cl, H, H (R); kk) F, H, H (S); ll) F, H, F (S); mm) F, H, Me (S) or nn) F, H, Me (R) and R is H or a prodrug such as methyl, ethyl, isopropyl, n-propyl, isobutyl, t-butyl, t-pentyl, n-pentyl, n-butyl, cyclohexylmethyl, 3-methyl-1-butyn-3 -yl, optionally N-protected-Ala, optionally N-protected-Phe, phthaloyl methyl ester, 4-diethylaminobenzoyl, 2-hydroxymethylbenzoyl, acetyl, t-butyloxycarbonyl, ethoxycarbonyl, phenoxycarbonyl, 4-nitrophenoxycarbonyl, 4-methoxyphenoxycarbonyl, 4-carbomethoxyphenoxycarbonyl, 4-methylphenoxycarbonyl, 4-fluorophenoxycarbonyl, 4-chlorophenoxycarbonyl, 2,6-dimethylphenoxycarbonyl, 1 -acetoxy-1-methyl-ethoxycarbonyl, benzyloxycarbonyl, pyrrolidin-1-ylcarbonyl, N-succinimidylmethyl or N-phthalimidylmethyl or a group of formula 1, 2 (where R' is H or Me), 3, 4 or 5 (where two azetidines are attached). A pharmaceutical composition thereof is useful in controlling pain in mammals. An intermediate compound of formula II is disclosed wherein: L is an anionic leaving group which may be displaced by a nucleophile and P is a nitrogen protecting group.
-
公开(公告)号:BR9714677A
公开(公告)日:2000-10-03
申请号:BR9714677
申请日:1997-12-10
Applicant: ABBOTT LAB
Inventor: HOLLADAY MARK W , ARNERIC STEPHEN P , BAI HAO , DART MICHAEL J , LIN NAN-HORNG , LYNCH JOHN K , OR YAT SUN , RYTHER KEITH B , SULLIVAN JAMES P , WASICAK JAMES T , EHRLICH PAUL P
IPC: A61P25/04 , A61K31/4427 , A61K31/443 , A61K31/4439 , A61K31/485 , A61P25/28 , A61P29/00 , C07D205/04 , C07D401/12 , C07D401/14 , C07D405/14 , A61K31/44
Abstract: The present invention relates to a method of controlling pain in mammals, including humans, comprising administering to a mammal or patient in need of treatment thereof selected compounds of formula (I) or a pharmaceutically acceptable salt thereof. The invention further relates to selected (R) and (S) compounds of formula (I) which are useful as analgesics as well as neuronal cell death preventors and anti-inflammatories.
-
公开(公告)号:CA2361525A1
公开(公告)日:2000-08-03
申请号:CA2361525
申请日:2000-01-25
Applicant: ABBOTT LAB
Inventor: BUNNELLE WILLIAM H , CRISTINA DANIELA BARLOCCO , DAANEN JEROME F , MEYER MICHAEL D , RYTHER KEITH B , DART MICHAEL J , SIPPY KEVIN B , SCHRIMPF MICHAEL R , TOUPENCE RICHARD B
IPC: A61K31/00 , A61K31/407 , A61K31/4355 , A61K31/4365 , A61K31/439 , A61K31/4439 , A61K31/444 , A61K31/4709 , A61K31/497 , A61K31/501 , A61K31/502 , A61P9/10 , A61P15/10 , A61P25/00 , A61P25/02 , A61P25/06 , A61P25/08 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , C07D401/08 , C07D471/08 , C07D487/08 , C07D491/048 , C07D495/04 , C07D519/00 , C07D209/00 , C07D221/00 , C07D241/00 , C07D243/00 , A61K31/395
Abstract: Compounds of formula (I) or a pharmaceutically acceptable salt thereof wherein: V is selected from the group consisting of a covalent bond and CH2; W is selected from the group consisting of a covalent bond, CH2 and CH2CH2; X is selected from the group consisting of a covalent bond and CH2; Y is selected from the group consisting of a covalent bond, CH2, and CH2CH2; Z is selected from the group consisting of CH2, CH2CH2, and CH2CH2CH2; L1 is selected from the group consisting of a covalent bond and (CH2)n; n is 1-5; R1 is selected from the group consisting of (a), (b), (c), (d), (e), (f), (g), (h), (i), (j ), (k), and (l); R2 is selected from the group consisting of hydrogen, alkoxycarbonyl, alkyl, aminoalkyl, aminocarbonylalkyl, benzyloxycarbonyl, cyanoalkyl, dihydro-3-pyridinylcarbonyl, hydroxy, hydroxyalkyl, phenoxycarbonyl, and -NH2; are useful for controlling synaptic transmission in mammal.
-
公开(公告)号:SK75999A3
公开(公告)日:2000-05-16
申请号:SK75999
申请日:1997-12-10
Applicant: ABBOTT LAB
Inventor: HOLLADAY MARK W , ARNERIC STEPHEN P , BAI HAO , DART MICHAEL J , LIN NAN-HORNG , LYNCH JOHN K , OR YAT SUN , RYTHER KEITH B , SULLIVAN JAMES P , WASICAK JAMES T , EHRLICH PAUL P
IPC: A61P25/04 , A61K31/4427 , A61K31/443 , A61K31/4439 , A61K31/485 , A61P25/28 , A61P29/00 , C07D205/04 , C07D401/12 , C07D401/14 , C07D405/14 , A61K31/44
Abstract: The present invention relates to a method of controlling pain in mammals, including humans, comprising administering to a mammal or patient in need of treatment thereof selected compounds of formula (I) or a pharmaceutically acceptable salt thereof. The invention further relates to selected (R) and (S) compounds of formula (I) which are useful as analgesics as well as neuronal cell death preventors and anti-inflammatories.
-
公开(公告)号:TR199901904T2
公开(公告)日:1999-10-21
申请号:TR9901904
申请日:1997-12-10
Applicant: ABBOTT LAB
Inventor: HOLLADAY MARK W , ARNERIC STEPHEN P , BAI HAO , DART MICHAEL J , LIN NAN-HORNG , LYNCH JOHN K , OR YAT SUN , RYTHER KEITH B , SULLIVAN JAMES P , WASICAK JAMES T , EHRLICH PAUL P
IPC: A61P25/04 , A61K31/4427 , A61K31/443 , A61K31/4439 , A61K31/485 , A61P25/28 , A61P29/00 , C07D205/04 , C07D401/12 , C07D401/14 , C07D405/14 , A61K31/44
Abstract: The present invention relates to a method of controlling pain in mammals, including humans, comprising administering to a mammal or patient in need of treatment thereof selected compounds of formula (I) or a pharmaceutically acceptable salt thereof. The invention further relates to selected (R) and (S) compounds of formula (I) which are useful as analgesics as well as neuronal cell death preventors and anti-inflammatories.
-
公开(公告)号:NO992705L
公开(公告)日:1999-08-03
申请号:NO992705
申请日:1999-06-03
Applicant: ABBOTT LAB
Inventor: HOLLADAY MARK W , ARNERIC STEPHEN P , BAI HAO , DART MICHAEL J , LIN NAN-HORNG , LYNCH JOHN K , OR YAT SUN , RYTHER KEITH B , SULLIVAN JAMES P , WASICAK JAMES T , EHRLICH PAUL P
IPC: A61P25/04 , A61K31/4427 , A61K31/443 , A61K31/4439 , A61K31/485 , A61P25/28 , A61P29/00 , C07D205/04 , C07D401/12 , C07D401/14 , C07D405/14 , A61K31/44
Abstract: The present invention relates to a method of controlling pain in mammals, including humans, comprising administering to a mammal or patient in need of treatment thereof selected compounds of formula (I) or a pharmaceutically acceptable salt thereof. The invention further relates to selected (R) and (S) compounds of formula (I) which are useful as analgesics as well as neuronal cell death preventors and anti-inflammatories.
-
38.
公开(公告)号:CA2315117A1
公开(公告)日:1999-07-01
申请号:CA2315117
申请日:1998-12-18
Applicant: ABBOTT LAB
Inventor: HE YUN , LEBOLD SUZANNE A , ELLIOTT RICHARD L , BAI HAO , DART MICHAEL J , WASICAK JAMES T , KINCAID JOHN F , GARVEY DAVID S , LI YIHONG , RYTHER KEITH , HOLLADAY MARK W , EHRLICH PAUL P , ABREO MELWYN A , GUNN DAVID E , LIN NAN-HORNG , SCHKERYANTZ JEFFREY M , LYNCH JOHN K
IPC: A61K31/427 , A61K31/4427 , A61K31/4439 , A61K31/4545 , A61K31/4709 , A61K31/4725 , A61K31/497 , A61K31/501 , A61K31/506 , A61P25/00 , A61P25/22 , A61P25/28 , A61P25/30 , A61P43/00 , C07D401/12 , C07D403/12 , C07D417/12 , C07D455/02 , C07D487/04 , A61K31/40 , A61K31/425 , A61K31/44 , A61K31/47 , A61K31/50 , A61K31/505
Abstract: Novel compounds having formulas (I), (II) or (III) or pharmaceuticallyacceptable salts or prodrugs thereof, which are useful for controlling synaptic transmission; to therapeutically-effective pharmaceutical compositions of these compounds; and to the use of said compositions to controlling synaptic transmission in human or veterinary patients.
-
公开(公告)号:CA2227695A1
公开(公告)日:1997-02-13
申请号:CA2227695
申请日:1996-07-25
Applicant: ABBOTT LAB
Inventor: RYTHER KEITH B , ELLIOTT RICHARD L , HOLLADAY MARK W , DAANEN JEROME F , WASICAK JAMES T , DART MICHAEL J
IPC: A61K31/00 , A61K31/435 , A61K31/4353 , A61K31/4355 , A61P9/00 , A61P25/00 , A61P25/30 , C07D471/04 , C07D487/04 , C07D491/04 , C07D491/044 , C07D491/048 , C07D495/04 , C07D519/00 , A61K31/495 , A61K31/53
Abstract: Novel heterocyclic ether compounds having the formula (I) wherein A, m, R, X, Y1, Y2 and Y3 are specifically defined, which are useful in selectively controlling chemical synaptic transmission; therapeutically-effective pharmaceutical compositions thereof; and use of said compositions to selectively control synaptic transmission in mammals.
-
公开(公告)号:PE08042011A1
公开(公告)日:2011-11-30
申请号:PE0006262011
申请日:2009-09-16
Applicant: ABBOTT LAB
Inventor: CARROLL WILLIAM A , DART MICHAEL J , FROST JENNIFER M , LATSHAW STEVEN P , KOLASA TEODOZYJ , LI TONGMEI , PEDDI SRIDHAR , LIU BO , PEREZ-MEDRANO ARTURO , PATEL MEENA , WANG XUEQING , NELSON DEREK W
IPC: C07D231/40 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/14 , C07D413/12 , C07D413/14
CPC classification number: C07D405/12 , C07D231/40 , C07D285/135 , C07D403/12 , C07D405/14 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12
Abstract: SE REFIERE A UN COMPUESTO DE FORMULA (I) DONDE X4 ES O, S, S(O), N(Rbx); Rbx ES H, ALQUILO, -C(O)O(ALQUILO); A1 ES -(CR1aR1b)q1-A2, -(CR1aR1b)q1-G1c, ENTRE OTROS; R1a Y R1b SON CADA UNO H, HALOGENO, ALQUILO C1-C4, ALQUILO C1-C4, ENTRE OTROS q1 ES 1-4; G1c ES CICLOALQUENILO, HETEROCICLO, ARILO, HETEROARILO; A2 ES -CO, -SO2, ENTRE OTROS; A5 ES DE PREFERENCIA PIRAZOL, 1,3,4-TIADIAZOL, ENTRE OTROS; RX ES C1-C4 ALQUILO, HALOGENO, NO2, ENTRE OTROS; z ES 0-4. SON COMPUESTOS PREFERIDOS: N-{(3E)-5-TERT-BUTIL-1-METIL-2-[(2R)-TETRAHIDROFURAN-2-ILMETIL]-1,2-DIHIDRO-3H-PIRAZOL-3-ILIDEN}-2-[(2R)-TETRAHIDROFURAN-2-ILMETOXI]-5-(TRIFLUOROMETIL)BENZAMIDA; N-[(2Z)-3-BUTIL-5-TERT-BUTIL-1,3,4-TIADIAZOL-2(3H)-ILIDEN]-2-(2-HIDROXI-2-METILPROPOXI)-5-(TRIFLUOROMETIL)BENZAMIDA; ENTRE OTROS. REFERIDA TAMBIEN A UNA COMPOSICION FARMACEUTICA QUE PRESENTA UN BIODISPONIBILIDAD ORAL MAYOR O IGUAL A 30%. DICHOS COMPUESTOS SON LIGANDOS DE RECEPTORES DE CANNABINOIDES UTIL EN EL TRATAMIENTO DEL DOLOR
-
-
-
-
-
-
-
-
-